
AcquisitionHealthcare & Life Sciences
Temple buys British longevity clinic Longevous
By Abha Lohia · Editor ·
Temple: valuation and funding and every story →
seedFounded 2025
- Temple creates a temple-mounted wearable sensor measuring brain blood circulation, oxygen levels, and metabolic demand
- Deepinder Goyal's venture bought London longevity clinic Longevous for an unstated price, absorbing its two founding doctors
- The transaction secures Temple an operating base inside Britain while it prepares initial consumer hardware shipments
What happened
- Temple bought London clinic Longevous for an unrevealed price.
- Longevous co-founders Dr Robert Mohr and Dr Avi Roy joined the buyer as full-time staff.
- Dr Mohr assumed the role of Chief Medical Officer at Temple.
- Dr Roy took charge of scientific initiatives as Head of Science.
- Longevous keeps running under Temple, allowing both practitioners to keep advising existing patients.
- The agreement grew out of a London dinner where the physicians spotted the forehead device worn by Deepinder Goyal.
- Temple plans to open pre-orders soon and deliver units before 2026 concludes.
Why it matters
- The purchase hands Temple an immediate foothold across the United Kingdom preventive healthcare landscape.
- Longevity medicine prioritises sustained wellness, early risk screening, and science-backed healthy ageing over standard disease intervention.
- Both incoming doctors evaluated the hardware for two months and scrutinized its core biological assumptions.
The business
- Temple builds a health sensor positioned on the side of the forehead instead of the wrist.
- The tracker records cerebral blood flow, oxygen saturation, and pulse variations during exercise, sleep, and rest.
- Its bespoke metric Entropy gauges bodily exertion and autonomic nervous demand on a scale from 1 to 250.
- The firm notes the hardware is sold for general wellness rather than clinical diagnosis or therapy.
- Manufacturing tie-ups with Zetwerk and Ethereal Machines support early hardware fabrication.
The founders
- Co-founded food delivery giant Eternal, formerly named Zomato.
- Stepped down as Eternal Group CEO in February 2026.
- Created aeronautics venture LAT Aerospace and wellness project Continue Research.
- Licensed medical practitioner with roughly twenty years of hospital and clinical work.
- Shifted focus from emergency wards toward data-driven preventative care and precision longevity.
AR
Avi Roy
Head of Science- Biomedical researcher educated at the University of Oxford.
- Co-founded digital health organisations Founders Health and UDA.
- Conducted academic investigations at Oxford's Centre for the Advancement of Sustainable Medical Innovation.
Who put in money
- Peak XV Partners existing — Backer in Temple's seed funding round.
- Steadview Capital existing — Backer in Temple's seed funding round.
- Dharana Capital existing — Backer in Temple's seed funding round.
- Info Edge Ventures existing — Backer in Temple's seed funding round.
In numbers
$54 millionSeed capital raised · 2026
$190 millionSeed post-money valuation · 2026
$375 millionSecondary ESOP programme valuation · 2026
100,000+First batch applications · 2026
What happens next
- Open advance orders for a limited introductory hardware edition.
- Ship initial wearable units to customers prior to the close of 2026.
- Produce an initial batch of several thousand devices for domestic and overseas distribution.
Earlier rounds
- 2026-02 · Seed · $54 million
Words to know
- Longevity medicine
- Clinical care aimed at keeping individuals disease-free longer through proactive monitoring and early lifestyle interventions.
- Entropy
- Temple's proprietary biological reading that tracks metabolic load and physical strain continuously.
The numbers around it
Temple has 2 funding rounds in StopDown's archive, $54M raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 28 February 2026 | friends-and-family | $54M | Deepinder Goyal |
| 5 February 2026 | pre-Series A | $3.3 Mn | V3 Ventures |
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
Indian Startup News ↗Moneycontrol ↗ani ↗medianama ↗startup-story-media ↗Outlook Business ↗Entrackr ↗Moneycontrol ↗Inc42 ↗Inc42 ↗Entrackr ↗
Terms in this story
- Medical device vs wellness wearable: In India a health wearable is treated as a medical device when its maker says it can diagnose, monitor, treat or prevent a disease. A gadget sold only for general fitness or wellness sits outside those rules, but its claims are still policed by consumer law.
Read next
NewsDoctors question Temple wearable's brain-flow claimsTemple makes a ₹85,000 wearable that tracks body signals, including blood flow near the head, and pairs the readings with AI insightsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Temple → · All startup news on 27 August 2026 →
Is this Temple? Get your “Featured on StopDown” badge →